NVNO Completes Application for VenoValve's PMA, Shares Likely to Gain [Yahoo! Finance]
ResMed Inc. (RMD)
Last resmed inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.resmed.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
in addressing unmet needs in the treatment of Chronic Venous Insufficiency (CVI). As a breakthrough-designated device, VenoValve aims to treat severe CVI by restoring proper blood flow and alleviating debilitating symptoms like leg swelling, pain, and venous ulcers. With approximately 2.5 million candidates for the device annually in the U.S., FDA approval could position enVVeno at the forefront of transforming the standard of care for venous disease. Subsequent to the news, the share price of NVNO dropped 5.5% to $3.41 yesterday. Although the shares are southbound, the latest development is likely to boost the company's bioprosthetic (tissue-based) solutions business. The company is gaining positive market acceptance for its progress with the treatment of CVI. The latest development is the fifth and final module of the FDA application containing favorable clinical data. The previous four modules had already been reviewed and approved by the FDA. Accordingly, the latest submissi
Show less
Read more
Impact Snapshot
Event Time:
RMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMD alerts
High impacting ResMed Inc. news events
Weekly update
A roundup of the hottest topics
RMD
News
- NEOG Stock Gains From New Addition to the Petrifilm Product Line [Yahoo! Finance]Yahoo! Finance
- With 74% institutional ownership, ResMed Inc. (NYSE:RMD) is a favorite amongst the big guns [Yahoo! Finance]Yahoo! Finance
- Why ResMed (RMD) is a Top Value Stock for the Long-Term [Yahoo! Finance]Yahoo! Finance
- ResMed Inc. (NYSE: RMD) is now covered by analysts at Stifel Nicolaus. They set a "hold" rating and a $250.00 price target on the stock.MarketBeat
- Zacks.com featured highlights include InterDigital, ResMed, Greenbrier Companies, Charles River Associates and Kontoor Brands [Yahoo! Finance]Yahoo! Finance
RMD
Earnings
- 10/24/24 - Beat
RMD
Sec Filings
- 12/11/24 - Form 4
- 12/9/24 - Form 144
- 12/5/24 - Form 4
- RMD's page on the SEC website